The Top 1%

October 10, 2026 By in David Weis, Linda Raschke, Spring-to-Up-Thrust, Up-Thrust, Wyckoff Leave a comment

Raschke, Weis and Wyckoff

The late David Weis once said he kept a copy of Wyckoff’s autobiography in his office, near him.

He made notes on it and marked it up so many times, the cover had fallen off.

His website (now deactivated) had a picture of him holding an original first edition Wyckoff ‘Studies In Tape Reading‘.

The last time I checked, that edition (if you could find one) in good condition, went for around $3,500.

All of this, ties-in with a recent interview of master trader, Linda Raschke, link here.

Wyckoff is specifically mentioned at time stamp: 10:52

In fact, just a few seconds later, we have a discussion on ‘springs’ and ‘up-thrusts’. 🙂

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Quarterly Chart … XBI

October 9, 2026 By in $SPSIBI, Biotech, SPBIO, XBI, XBI-26-21 Leave a comment

The Really Big Picture

One of the few indices or sectors that has not made new all-time highs, is Biotech XBI.

In the case at left, XBI spent an entire quarter pinned against resistance, going nowhere.

Now, in the first week or so of the current quarter, XBI is edging away from the highs (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

CarMax Stays in Lane

October 8, 2026 By in KMX, Transportation Leave a comment

Like Many Others

The last update on KMX, is here.

It said the retrace to 23.6%, was “exceedingly weak”.

We can see proof of that as KMX has reversed near the 23.6% retrace and is now in a downward channel (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Price is (always) Right

October 7, 2026 By in $SPSIBI, LABD, LABD-26-18, SNDK, SPBIO, XBI Leave a comment

XBI, Two Days Later

The last post on biotech (LABD) was here, showing a potential trendline.

Next day, within minutes of the open, XBI began a collapse and inverse fund LABD launched higher, finishing up +9.93%, for the day.

From an analysis standpoint, the dramatic action suggests trendline(s) may need to be re-drawn.

We’re going to switch back to the XBI ETF, as it shows the situation more clearly.

Biotech XBI, Daily

There may be other channels in effect, yet to reveal themselves.

Expectation is for continued lower action, it’s up to the market.

The channel could easily be negated if tomorrow is decidedly higher as just happened with SNDK (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

SanDisk ‘Sleeper Channel’

October 6, 2026 By in SNDK, Up-Thrust 1 Comment

Once You See It

SNDK posted an up-thrust at Day 1.

Then, went to a support low at Day 5.

After that, up for a test at Day 8

It seems hardly noticeable, but there’s a channel.

At this juncture, that channel is declining at -99% annualized (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Decision Point … Biotech

October 5, 2026 By in $SPSIBI, Biotech, LABD, LABD-26-18, SPBIO, XBI, XBI-26-17 1 Comment

At The Edge of Trend

We’re looking at biotech XBI, from the perspective of the 3X Leveraged Inverse Fund, LABD.

During the past four trading days, there have been three contact (verification) points on the right-most trendline.

Note that five trading days ago, LABD had its highest volume day, ever.

Trade Note:

The XBI-26-17 (short) was exited at about break-even, then re-positioned via LABD, as LABD-26-18 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech’s Bearish Condition

October 4, 2026 By in $SPSIBI, BBIO, SPBIO, Speck-Effect, The Speck, XBI, XBI-26-17 Leave a comment

Technical First

Depending on price action, the next several updates on XBI, will discuss the technical condition.

Then, we’ll get into behind-the-scenes or ‘fundamentals’.

With that said, we’ll start with the big picture, long timeframe; Fibonacci 8-Day

Biotech XBI, 8-Day

Price action has made it all the way back to 2021 manic highs, and stalled.

A potential double top.

Not present back in 2021, was the bearish (divergent) momentum condition highlighted by MACD histogram.

So, we have a potential double top, a terminating wedge and bearish MACD.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

S&P … Almost ‘There’

October 3, 2026 By in $SPSIBI, AZO, Biotech, BKNG, DUOL, HD, KMX, LOW, S&P, S&P 500, Semiconductors, SPBIO, Speck-Effect, SPY, The Speck, XBI, XBI-26-17 Leave a comment

‘There’, is a new All-Time High

Two weeks ago, was this update showing the (net) upward progress of the S&P was slowing (not advice, not a recommendation).

Then, two days later was this, presenting how the index might make it to another high.

Now, the SPY chart is mimicking the longer timeframe by having successive shorter thrusts (magenta arrows).

At this point it’s a toss-up but does it really matter?

Meaning, if the downside is being worked (shorted), large numbers of tickers are already in essentially free-fall: AZO, BKNG, DUOL, HD, KMX, LOW; way below their all-time highs (not advice, not a recommendation).

Note: All have been covered at some point, on this site.

One sector that’s not cracked (yet) but seems to be building up immense pressure, is biotech.

Barring any unforeseen event, XBI is covered next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

CarMax … ‘Exceedingly Weak’

October 2, 2026 By in KMX, Transportation 1 Comment

Fibonacci 23.6%, Retrace

Looking at CarMax from its all-time highs to now, the retrace to 23.6% (if it holds) is exceedingly weak (not advice, not a recommendation).

The last update on KMX was here, indicating a potential reversal and test.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Using Volume Clues

October 1, 2026 By in $SPSIBI, Bert Dohmen, LABD, SPBIO Leave a comment

Leveraged Professionals

Leveraged funds, especially 3X biotech inverse fund LABD, is likely to weed out (bankrupt) an inexperienced participant in due time.

With that said, we have to at least concede there are some deep pocket professionals participating in the same fund during the same hours as our market neophytes.

So, when volume behaves in a way uncharacteristic to the market, something’s up … or about to be up.

Biotech 3X Leveraged Inverse Fund LABD, 1-minute.

The volume spike indicates capitulation or a big player has just moved in.

At the blue ‘arrow’, there are three one-minute bars.

The long entry took place during the second bar (not advice, not a recommendation).

The next chart shows the result.

As Bert Dohmen has said countless times during recent interviews, ‘Nobody looks at volume’.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279